Santa Cruz Biotechnology offers a broad range of PILRα-β monoclonal antibodies for investigating immune receptor functions. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PILRα and PILRβ play essential roles in the immune system as inhibitory receptors that modulate immune responses. The receptors are involved in regulating immune cell activation, which is crucial for maintaining immune homeostasis and preventing excessive inflammation. Understanding PILRα and PILRβ signaling pathways and interactions provides valuable insights into autoimmune disorders and cancer development. Researchers can explore the complex mechanisms of immune cell regulation through detailed analysis of PILRα and PILRβ expression patterns. Advanced visualization techniques using fluorescent conjugates like horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) enable precise detection of PILRα and PILRβ in various experimental settings. The high specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies empower researchers worldwide to advance scientific understanding of immune system regulation.